Lowering the dose of hydroxyurea minimizes toxicity and maximizes anti-HIV potency.
Lori F, Pollard RB, Whitman L, Bakare N, Blick G, Shalit P, Foli A, Peterson D, Tennenberg A, Schrader S, Rashbaum B, Farthing C, Herman D, Norris D, Greiger P, Frank I, Groff A, Lova L, Asmuth D, Lisziewicz J.
Lori F, et al.
AIDS Res Hum Retroviruses. 2005 Apr;21(4):263-72. doi: 10.1089/aid.2005.21.263.
AIDS Res Hum Retroviruses. 2005.
PMID: 15943568
Clinical Trial.